Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Cefotaxime
- Therapeutic area
- Anti-infectives
- Drug class
- Third-generation cephalosporins
- ATC
- J01DD
- Strength
- 250 mg
- Dosage form
- Injection
- Pack
- 1Vial
- Registration no.
- 050662
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 105.67 to 110.89 (+4.9%) between 2 Oct 2025 and 17 Aug 2026 · 2 official price records · pack 1Vial
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Rasco Pharmafin 250 mg, 1Vial: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rasco-pharmafin-250-mg-050662-1vial-rasco-pharma/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 110.89 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 105.67 | 2025-10-02 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 050662Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
